TABLE OF CONTENTS
Detailed Table of Contents
Chapter 1 — Executive Summary
1.1Global CGM Market Overview
1.2Key Research Findings and Market Highlights
1.3Global Market Revenue, 2021–2035 (USD Billion)
1.4Market Growth Outlook and Forecast Assumptions
1.5Leading Product, Application, Technology, and End-User Segments
1.6Regional Market Leadership and Growth Opportunities
1.7Competitive Positioning of Leading CGM Manufacturers
1.8Key Investment Opportunities and Strategic Recommendations
Chapter 2 — Research Scope and Methodology
2.1Research Objectives and Scope
2.2Market Definition and Revenue Recognition Framework
2.3Inclusion and Exclusion Criteria
2.3.1Continuous Glucose Monitoring Sensors
2.3.2Transmitters, Receivers, and Integrated CGM Systems
2.3.3Standalone and Insulin-Pump-Integrated CGM Devices
2.3.4Exclusion of SMBG Test Strips, Glucose Meters, and Insulin Pumps
2.4Primary and Secondary Research Methodology
2.5Bottom-Up Manufacturer-Revenue Reconciliation
2.5.1Abbott CGM Revenue Assessment
2.5.2Dexcom CGM Revenue Assessment
2.5.3MiniMed / Medtronic CGM Revenue Assessment
2.5.4Senseonics and Ascensia Revenue Assessment
2.5.5MicroTech Medical and Chinese CGM Manufacturers
2.5.6Other Manufacturers and Revenue Normalization
2.6Calendar-Year and Fiscal-Year Revenue Adjustments
2.7Geographic Revenue Allocation Methodology
2.8Market Forecasting Model and Key Assumptions
2.9Currency Conversion and Data Triangulation
2.10Research Limitations and Sensitivity Analysis
Chapter 3 — Global CGM Market Dynamics
3.1Market Overview and Industry Evolution
3.2Market Drivers
3.2.1Increasing Global Diabetes Prevalence
3.2.2Rising Adoption of CGM in Type 1 Diabetes
3.2.3Expansion into Insulin-Treated Type 2 Diabetes
3.2.4Improved Sensor Accuracy and Extended Wear Duration
3.2.5Expanding Insurance Coverage and Reimbursement
3.2.6Growing Adoption of Automated Insulin Delivery Systems
3.2.7Smartphone Connectivity and Cloud-Based Diabetes Management
3.3Market Restraints
3.3.1High Recurring Sensor Costs
3.3.2Uneven Reimbursement Across Countries
3.3.3Limited Access in Emerging Markets
3.3.4Accuracy, Calibration, and Skin-Adhesion Concerns
3.3.5Data Privacy and Interoperability Challenges
3.4Market Opportunities
3.4.1Non-Insulin-Treated Type 2 Diabetes Population
3.4.2Primary Care and Community-Based Diabetes Management
3.4.3Emerging-Market Distribution Expansion
3.4.4Over-the-Counter and Consumer CGM Products
3.4.5Artificial Intelligence and Predictive Glucose Analytics
3.5Market Challenges and Industry Risks
3.6Regulatory and Reimbursement Trends
3.7Impact of Pricing Pressure and Competitive Innovation
Chapter 4 — Technology and Innovation Landscape
4.1Evolution of CGM Technology
4.2Real-Time CGM and Intermittently Scanned CGM
4.3Enzymatic and Electrochemical Glucose Sensing
4.4Implantable CGM Technology
4.5Sensor Miniaturization and Wear-Duration Improvements
4.6Factory Calibration and Sensor Accuracy
4.7Bluetooth, Smartphone, and Cloud Connectivity
4.8CGM Integration with Insulin Pumps and Automated Insulin Delivery
4.9Artificial Intelligence and Predictive Glucose Monitoring
4.10Emerging Noninvasive and Minimally Invasive Technologies
4.11Product Development Pipeline and Future Technology Outlook
Chapter 5 — Global CGM Market Analysis by Product Type
5.1Overview and Revenue Share by Product Type, 2025 and 2035
5.2Sensors
5.2.1Market Size and Forecast, 2021–2035
5.2.2Revenue Leadership and Recurring Replacement Demand
5.2.3Sensor Accuracy, Wear Duration, and Pricing Trends
5.3Transmitters
5.3.1Market Size and Forecast, 2021–2035
5.3.2Reusable versus Integrated Transmitter Architectures
5.4Receivers
5.4.1Market Size and Forecast, 2021–2035
5.4.2Transition toward Smartphone-Based Monitoring
5.5Integrated CGM Systems
5.5.1Market Size and Forecast, 2021–2035
5.5.2Adoption of All-in-One Sensor Platforms
5.6Other CGM-Related Products and Services
5.7Largest and Fastest-Growing Product Segments
5.8Product Segment Competitive Analysis
Chapter 6 — Global CGM Market Analysis by Technology
6.1Technology Segment Overview
6.2Real-Time Continuous Glucose Monitoring (rtCGM)
6.2.1Market Size and Forecast
6.2.2Adoption Drivers and Clinical Advantages
6.3Intermittently Scanned CGM (isCGM)
6.3.1Market Size and Forecast
6.3.2Market Position and Technology Transition
6.4Implantable Continuous Glucose Monitoring
6.4.1Market Size and Forecast
6.4.2Long-Wear Technology and Adoption Outlook
6.5Largest and Fastest-Growing Technology Segments
6.6Technology Adoption Trends by Region
Chapter 7 — Global CGM Market Analysis by Application
7.1Application Segment Overview
7.2Type 1 Diabetes Management
7.2.1Market Size and Forecast
7.2.2Clinical Adoption and Reimbursement
7.3Type 2 Diabetes — Intensive Insulin Therapy
7.3.1Market Size and Forecast
7.3.2Integration with Insulin Delivery
7.4Type 2 Diabetes — Basal Insulin Therapy
7.4.1Market Size and Forecast
7.4.2Expanding Coverage and Clinical Utilization
7.5Type 2 Diabetes — Non-Insulin-Treated Patients
7.5.1Market Size and Forecast
7.5.2Emerging Clinical and Commercial Opportunities
7.6Gestational Diabetes and Other Clinical Applications
7.7Consumer Metabolic Health and Wellness Applications
7.8Largest and Fastest-Growing Application Segments
7.9Application Adoption Outlook, 2026–2035
Chapter 8 — Global CGM Market Analysis by End User
8.1End-User Segment Overview
8.2Homecare and Self-Management
8.2.1Market Size and Forecast
8.2.2Dominance of Recurring Personal Sensor Use
8.3Hospitals and Inpatient Care
8.3.1Market Size and Forecast
8.3.2Clinical Adoption and Regulatory Considerations
8.4Diabetes Specialty Clinics
8.4.1Market Size and Forecast
8.4.2Patient Onboarding and Clinical Monitoring
8.5Other End Users
8.6Largest and Fastest-Growing End-User Segments
8.7End-User Adoption and Distribution Trends
Chapter 9 — Global CGM Market Analysis by Distribution Channel
9.1Distribution Channel Overview
9.2Retail Pharmacies
9.3Hospital Pharmacies and Institutional Procurement
9.4Online Pharmacies and Direct-to-Consumer Channels
9.5Durable Medical Equipment and Specialist Distributors
9.6Manufacturer-Direct Distribution
9.7Revenue Share and Growth by Distribution Channel
9.8Reimbursement and Channel Economics
Chapter 10 — Global CGM Market — Regional Analysis
10.1Global Regional Market Overview
10.2Regional Revenue Comparison, 2025 and 2035
10.3Regional Market Shares and CAGR Comparison
10.4North America CGM Market
10.4.1Market Size and Forecast, 2021–2035
10.4.2United States
10.4.3Canada
10.4.4Mexico
10.4.5Reimbursement, Adoption, and Competitive Dynamics
10.5Europe CGM Market
10.5.1Market Size and Forecast, 2021–2035
10.5.2Germany
10.5.3United Kingdom
10.5.4France
10.5.5Italy
10.5.6Spain
10.5.7Rest of Europe
10.5.8National Reimbursement and Regulatory Differences
10.6Asia Pacific CGM Market
10.6.1Market Size and Forecast, 2021–2035
10.6.2China
10.6.3Japan
10.6.4India
10.6.5South Korea
10.6.6Australia
10.6.7Rest of Asia Pacific
10.6.8Local Manufacturing and Access Expansion
10.7Latin America CGM Market
10.7.1Market Size and Forecast, 2021–2035
10.7.2Brazil
10.7.3Argentina
10.7.4Rest of Latin America
10.7.5Affordability and Distribution Dynamics
10.8Middle East & Africa CGM Market
10.8.1Market Size and Forecast, 2021–2035
10.8.2Saudi Arabia
10.8.3United Arab Emirates
10.8.4South Africa
10.8.5Rest of Middle East & Africa
10.8.6Public and Private Healthcare Access
10.9Largest Regional Market and Factors Supporting Leadership
10.10Fastest-Growing Region and Underlying Growth Drivers
10.11Regional Opportunities and Forecast Risks
Chapter 11 — Country-Level CGM Market Reconciliation
11.1Manufacturer-Revenue Allocation by Country
11.2U.S. CGM Market
11.2.1Revenue Reconciliation with Abbott and Dexcom
11.2.2Medicare, Commercial Insurance, and CGM Coverage
11.2.3CGM versus SMBG Market Evolution and Revenue Crossover
11.3Germany CGM Market
11.3.1Reimbursement and Statutory Health Insurance
11.3.2Product Availability and Adoption
11.4Japan CGM Market
11.4.1Regulatory Approvals and Reimbursement
11.4.2Market Penetration and Adoption Barriers
11.5China CGM Market
11.5.1Domestic and International Manufacturer Revenues
11.5.2Local Competition and Distribution
11.6Italy CGM Market
11.6.1Regional Healthcare Reimbursement Differences
11.6.2Patient Access and Adoption
11.7South Africa CGM Market
11.7.1Private and Public Healthcare Demand
11.7.2Affordability and Market Penetration
11.8Reconciliation of Six-Country Revenue with Global Market
11.9Rest-of-World Revenue Assessment
11.10Country-Level Forecast Consistency and Sensitivity Analysis
Chapter 12 — Competitive Landscape
12.1Global Competitive Environment
12.2Market Concentration and Manufacturer Revenue Shares
12.3Leading Manufacturers and Competitive Positioning
12.4Product Portfolio and Technology Benchmarking
12.5Pricing, Distribution, and Reimbursement Strategies
12.6Strategic Partnerships and Collaborations
12.7Product Launches and Regulatory Approvals
12.8Mergers, Acquisitions, and Geographic Expansion
12.9Emerging Chinese Manufacturers and Competitive Disruption
12.10Competitive Outlook, 2026–2035
Chapter 13 — Company Profiles
13.1Abbott Laboratories
13.2Dexcom, Inc.
13.3MiniMed / Medtronic Diabetes
13.4Senseonics Holdings, Inc.
13.5Ascensia Diabetes Care
13.6MicroTech Medical (Hangzhou)
13.7Sinocare Inc.
13.8Other Relevant CGM Manufacturers
Each company profile covers company overview, CGM portfolio, available financial information, geographic presence, strategic developments, and competitive positioning.
Chapter 14 — Market Forecast and Strategic Outlook
14.1Global CGM Revenue Forecast, 2026–2035
14.2Forecast by Product Type
14.3Forecast by Technology
14.4Forecast by Application
14.5Forecast by End User
14.6Forecast by Distribution Channel
14.7Forecast by Region and Country
14.8Sensor Pricing and Utilization Assumptions
14.9CGM Adoption and Installed-User Growth
14.10Base, Optimistic, and Conservative Forecast Scenarios
14.11Emerging Technology and Competitive Risks
14.12Strategic Recommendations for Manufacturers and Investors
Chapter 15 — Appendix
15.1Market Definitions and Terminology
15.2Manufacturer Revenue Reconciliation Tables
15.3Historical and Forecast Market Data
15.4Country and Regional Allocation Assumptions
15.5Currency Conversion Methodology
15.6Research Sources and References
15.7Abbreviations and Acronyms
15.8Disclaimer and Research Limitations